[go: up one dir, main page]

ES2115668T3 - Tratamiento contra las ulceraciones de los tejidos. - Google Patents

Tratamiento contra las ulceraciones de los tejidos.

Info

Publication number
ES2115668T3
ES2115668T3 ES92902666T ES92902666T ES2115668T3 ES 2115668 T3 ES2115668 T3 ES 2115668T3 ES 92902666 T ES92902666 T ES 92902666T ES 92902666 T ES92902666 T ES 92902666T ES 2115668 T3 ES2115668 T3 ES 2115668T3
Authority
ES
Spain
Prior art keywords
alkyl
ulcerations
tissues
treatment against
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92902666T
Other languages
English (en)
Inventor
Richard E Galardy
Damian Grobelny
Gregory Schultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Application granted granted Critical
Publication of ES2115668T3 publication Critical patent/ES2115668T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/02—Carbamic acids; Salts of carbamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Processing Of Meat And Fish (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

COMPUESTO DE LA FORMULA (1) O (2) DONDE R1 ES H Y R2 ES ALQUILO (C3 H2)N DONDE N=3-5; R3 ES H O ALQUILO (C1 X ES OR5 O NHR5, DONDE R5 ES H O ALQUILO (C1 O NO SUSTITUIDO, ARILO (C6 UN RESIDUO DE AMINOACIDO O AMIDA CONSIGUIENTE; O X ES EL RESIDUO DE UNA AMINA CICLICA O AMINA HETEROCICLICA, SON UTILES PARA EL TRATAMIENTO O PREVENCION DE ULCERACION DE TEJIDO, EN ESPECIAL LA CORNEA.
ES92902666T 1990-11-21 1991-11-21 Tratamiento contra las ulceraciones de los tejidos. Expired - Lifetime ES2115668T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/616,021 US5114953A (en) 1990-11-21 1990-11-21 Treatment for tissue ulceration

Publications (1)

Publication Number Publication Date
ES2115668T3 true ES2115668T3 (es) 1998-07-01

Family

ID=24467733

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92902666T Expired - Lifetime ES2115668T3 (es) 1990-11-21 1991-11-21 Tratamiento contra las ulceraciones de los tejidos.

Country Status (9)

Country Link
US (1) US5114953A (es)
EP (1) EP0558681B1 (es)
JP (1) JPH06102626B2 (es)
AT (1) ATE164767T1 (es)
AU (1) AU652016B2 (es)
CA (1) CA2096223C (es)
DE (1) DE69129236T2 (es)
ES (1) ES2115668T3 (es)
WO (1) WO1992009282A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5270326A (en) * 1990-11-21 1993-12-14 University Of Florida Treatment for tissue ulceration
US5892112A (en) * 1990-11-21 1999-04-06 Glycomed Incorporated Process for preparing synthetic matrix metalloprotease inhibitors
US5189178A (en) * 1990-11-21 1993-02-23 Galardy Richard E Matrix metalloprotease inhibitors
US5239078A (en) * 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
US5268384A (en) * 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
US5889058A (en) * 1990-12-03 1999-03-30 Celltech Limited Peptidyl derivatives
WO1992022523A2 (en) * 1991-06-14 1992-12-23 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor
US5646167A (en) * 1993-01-06 1997-07-08 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamix acids
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5552419A (en) * 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5506242A (en) * 1993-01-06 1996-04-09 Ciba-Geigy Corporation Arylsufonamido-substituted hydroxamic acids
EP0692931A4 (en) * 1993-04-07 1996-03-20 Glycomed Inc SYNTHETIC INHIBITORS OF MATRIX METALLOPROTEASE AND USES
KR20090090403A (ko) 1993-07-19 2009-08-25 더 유니버시티 오브 브리티쉬 콜롬비아 항맥관형성 조성물, 당해 조성물로 피복된 스텐트 및 당해 스텐트의 제조방법
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
US6037472A (en) * 1993-11-04 2000-03-14 Syntex (U.S.A.) Inc. Matrix metalloprotease inhibitors
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
EP0763012B1 (en) * 1994-05-28 1999-06-09 British Biotech Pharmaceuticals Limited Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
BR9609883A (pt) * 1995-08-08 1999-03-23 Fibrogen Inc Composto tendo efeito inibidor em proteinase c composição farmacéutica e processo para tratar doenças relacionadas com a produção inapropriada ou desregulada de colágeno
AU3729397A (en) * 1996-08-16 1998-03-06 Warner-Lambert Company Butyric acid matrix metalloproteinase inhibitors
WO1999065867A1 (en) 1998-06-17 1999-12-23 Du Pont Pharmaceuticals Company Cyclic hydroxamic acids as metalloproteinase inhibitors
US6187907B1 (en) 1998-08-31 2001-02-13 James Chen Triple helix coil template having a biologically active ligand
US20040122011A1 (en) * 1998-12-23 2004-06-24 Pharmacia Corporation Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
AU2002367925A1 (en) * 2001-09-25 2003-11-11 Quick Med Technologies, Inc. Composition and method for minimizing or avoiding adverse effects of vesicants
PE20030701A1 (es) * 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
WO2003101381A2 (en) * 2002-05-29 2003-12-11 Merck & Co., Inc. 1,2 diamido cycloalkyl sodium channel blockers
US20080139512A1 (en) * 2002-09-25 2008-06-12 Quick-Med Technologies, Inc. Method for minimizing or avoiding adverse effects of vesicants
AU2004240629B2 (en) * 2003-05-16 2010-02-25 Arriva Pharmaceuticals, Inc. Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors
EP2287326A1 (en) * 2003-08-08 2011-02-23 Arriva Pharmaceuticals, Inc. Methods of protein production in yeast
ATE530165T1 (de) * 2003-11-14 2011-11-15 Baxter Int Alpha1-antitrypsin-zusammensetzungen und behandlungsverfahren unter verwendung dieser zusammensetzungen
CA2559062A1 (en) * 2004-03-09 2005-09-22 Arriva Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
US20070105768A1 (en) * 2004-11-10 2007-05-10 Rajiv Nayar Dry recombinant human alpha 1-antitrypsin formulation
GB0703677D0 (en) * 2007-02-26 2007-04-04 Surface Therapeutics Ltd Novel compounds
GB0722484D0 (en) * 2007-11-15 2007-12-27 Ucl Business Plc Solid compositions
US8435541B2 (en) 2010-09-02 2013-05-07 Bath & Body Works Brand Management, Inc. Topical compositions for inhibiting matrix metalloproteases and providing antioxidative activities

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291048A (en) * 1978-07-06 1981-09-22 Joseph Gold Method of treating tumors and cancerous cachexia with L-tryptophan
JPS5758626A (en) * 1980-09-26 1982-04-08 Rikagaku Kenkyusho Carcinostatic agent
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
US4558034A (en) * 1984-01-31 1985-12-10 The Board Of Trustees Of The University Of Kentucky Inhibitors of bacterial collagenase
DE3482590D1 (de) * 1984-04-12 1990-08-02 Searle & Co Carboxyalkyl-peptid-derivate.
US4698342A (en) * 1985-07-16 1987-10-06 Serotonin Industries Of Charleston Method and compositions for controlling pain, depression and sedation
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4599361A (en) * 1985-09-10 1986-07-08 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
ZW23187A1 (en) * 1986-12-15 1988-06-29 Hoffmann La Roche Phosphinic acid derivatives
FR2609289B1 (fr) * 1987-01-06 1991-03-29 Bellon Labor Sa Roger Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes
JPH01146896A (ja) * 1987-12-04 1989-06-08 Fuji Yakuhin Kogyo Kk 新規なペプチジルヒドロキサム酸誘導体

Also Published As

Publication number Publication date
EP0558681A4 (en) 1993-11-18
CA2096223A1 (en) 1992-05-22
AU9135191A (en) 1992-06-25
EP0558681B1 (en) 1998-04-08
JPH06102626B2 (ja) 1994-12-14
JPH05508164A (ja) 1993-11-18
CA2096223C (en) 2002-09-24
DE69129236T2 (de) 1998-09-17
DE69129236D1 (de) 1998-05-14
ATE164767T1 (de) 1998-04-15
WO1992009282A1 (en) 1992-06-11
EP0558681A1 (en) 1993-09-08
US5114953A (en) 1992-05-19
AU652016B2 (en) 1994-08-11

Similar Documents

Publication Publication Date Title
ES2115668T3 (es) Tratamiento contra las ulceraciones de los tejidos.
ES2109335T3 (es) Inhibidores mejorados de metaloproteasa matricial.
DE69133385D1 (de) Verbesserte matrix-metallprotease-inhibitoren
HU885892D0 (en) Herbicides containing as active substance derivatives of 3-phenil-uracyl and process for production of the active substances
DE19680619D2 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
SE8303208L (sv) Heterocykliska foreningar
SE8804586D0 (sv) 1,4-dihydro-4-oxonaftyridinderivat och salter daerav foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa
NO832923L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive 4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyridin-derivater
SE8305950D0 (sv) Novel 4-oxo-1,4-dihydronicotinic acid derivatives and salts thereof, process for producing the same, and antibacterial agents containing the same
NO893480D0 (no) Fremgangsmaate for fremstilling av disubstituerte benzylaminer.
ES2056860T3 (es) Derivados de n-((2-oxopirrolidin-1-il)-acetil)piperazina y medicamento contra la demencia senil.
DK511383D0 (da) Fremgangsmade til fremstilling af piperidindionderivater,der beskytter hjertemuskulaturen med en antiarythmisk aktivitet
ATE70274T1 (de) Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide.
NO833528L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutan-derivater
SE9001269D0 (sv) 2-substituted n,n-ditrimethoxybenzoyl piperazines,a preparation process of the same and therapeutic compositions containing them
ATE124685T1 (de) 4-phenylmethyl-1h-indol-derivate, verfahren und zwischenverbindungen zu deren herstellung, anwendung als arzneimittel und diese enthaltende zusammensetzungen.
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
DE3474145D1 (en) Benzothiazolone derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
FR2778404B1 (fr) Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
NO931803L (no) Behandling av vevsulkerasjon
ATE79752T1 (de) Verwendung von chromanderivaten zur herstellung eines medikamentes zur behandlung von depressiven zustaenden.
NO883387L (no) Fremgangsmaate for fremstilling av 2'-deoksy-5-fluoruridinderivater.
ATE92919T1 (de) Heterocyclische phenylaether, verfahren zu deren herstellung und diese enthaltende herbizide mittel.
ATE8633T1 (de) Vinyl-3-cephalosporinverbindungen und ihre herstellung.
DK378382A (da) N-substituerede tetrahydroisophthalimidderivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 558681

Country of ref document: ES